Bosentan | Info

Bosentan is a dual endothelin receptor antagonist used in the treatment of pulmonary artery hypertension (PAH). It is licensed in the United States , the European Union and other countries by Actelion Pharmaceuticals for the management of PAH under the trade name Tracleer .